Advancements in Cardiovascular and Antidiabetic Drug ... - MDPI
In this review we will discuss the advantage of nanotechnology-mediated drug delivery and assess the effectiveness of sEVs as nanocarriers to modulate specific ...
Oral peptide therapeutics for diabetes treatment: State-of-the-art and ...Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin delivery. Proc Natl Acad Sci USA 2015; ... Obesity wars: hypothalamic sEVs a new hopeThe patch consisted of a drug (Rosi) and 2 enzymes, glucose oxidase and catalase, which were encapsulated into biodegradable dextran NPs. The ... Transforming diabetes care: Latest advancements in treatment and ...Tirzepatide, introduced by Eli Lilly in May 2022, recorded sales of USD 2. 958 billion over the same period. https://www.fiercepharma. com ...
Autres Cours:
